DRMA logo

Dermata Therapeutics (DRMA)

Profile

Full Name

Dermata Therapeutics, Inc.

Ticker Symbol

DRMA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 13, 2021

Indexes

Not included

Website

http://www.dermatarx.com

Employees

8

Key Details

Price

$0.73(+2.68%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$8.03(+79.92% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.73
DRMA price is $0.73

30-Day Relative Volume

0.02
DRMA 30-day relative volume is 0.02

Price Performance

Price Most recent change

+2.68%
DRMA price was up +2.68% on Apr 17, 2025

Price YTD change

-46%
DRMA price is down -46% since January 1st

Price 1-year change

-83.53%
DRMA price is down -83.53% year-on-year

Price 3-year change

-99.73%
DRMA price is down -99.73% over the past 3 years

Price Range

Price All-time high

$1668.00
DRMA price is currently -99.96% below its historical high of $1668.00

Price 3-year low

$0.70
DRMA price is currently +4.14% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.96M
DRMA market capitalization is $3.96 million

Market cap 3-year change

-58.48%
DRMA market capitalization is down -58.48% over the past 3 years

Market cap All-time high

$52.05M
DRMA market capitalization is currently -92.39% below its historical high of $52.05 million

Market cap sector rank

11.28%
DRMA market capitalization is higher than 11.28% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1122.83%
DRMA shares outstanding is up +1122.83% year-on-year

Shares Outstanding 3-Year Change

+15550.14%
DRMA shares outstanding is up +15550.14% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.62
DRMA beta is -0.62

200-day SMA

$1.46
DRMA price is currently -50.15% below its 200-day simple moving average

50-day SMA

$1.11
DRMA price is currently -34.16% below its 50-day simple moving average

RSI

27.75
DRMA 14-day relative strength index is 27.75

Volume

0.02
DRMA 30-day relative volume is 0.02

ATR

$0.10
DRMA average true range is $0.10

10-day Historical Volatility

69.02%
DRMA 10-day historical volatility is 69.02%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
DRMA annual revenue value is unknown

Revenue Analysts estimate

-
DRMA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
DRMA annual revenue 1-year change is unknown

Revenue Sector rank

-
DRMA annual revenue is unknown

EPS

EPS

-$8.03
DRMA annual earnings per share is -$8.03

EPS Analysts estimate

-$3.87
DRMA annual earnings per share is currently +107.49% higher than the consensus analysts' forecast

EPS 1-year change

+79.92%
DRMA annual earnings per share is up +79.92% year-on-year

EPS Sector rank

13.67%
DRMA annual earnings per share is higher than 13.67% of companies in Healthcare sector

Profit

Gross profit

-
DRMA annual gross profit value is unknown

Gross margin

-
DRMA annual gross profit margin value is unknown

Operating profit

-$12.51M
DRMA annual operating income is -$12.51 million

Operating margin

-
DRMA annual operating profit margin value is unknown

Net income

-$12.29M
DRMA annual net profit is -$12.29 million

Net margin

-
DRMA annual net profit margin value is unknown

Expenses

Total expenses

$12.51M
DRMA annual total expenses is $12.51 million

Operating expenses

$12.51M
DRMA annual total operating expenses is $12.51 million

Cost of goods sold

-
DRMA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.31M
DRMA annual SGA is $4.31 million

Depreciation and amortization

-
DRMA annual depreciation & amortization value is unknown

Interest expense

-
DRMA annual interest expense value is unknown

Income tax

-
DRMA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$12.51M
DRMA annual earnings before interest & taxes is -$12.51 million

EBITDA

-$12.51M
DRMA annual EBITDA is -$12.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.53M
DRMA annual total assets is $3.53 million

Non current assets

$0.00
DRMA annual long term assets is $0.00

Current assets

$3.53M
DRMA annual total current assets is $3.53 million

Cash and cash equivalents

$3.16M
DRMA annual cash & cash equivalents is $3.16 million

Accounts receivable

-
DRMA annual accounts receivable value is unknown

Inventory

-
DRMA annual inventory value is unknown

Liabilities

Total liabilities

$1.97M
DRMA annual total liabilities is $1.97 million

Long term liabilities

$0.00
DRMA annual total long term liabilities is $0.00

Current liabilities

$1.97M
DRMA annual total current liabilities is $1.97 million

Accounts payable

$808.00K
DRMA annual accounts payable is $808.00 thousand

Debt

Total debt

$0.00
DRMA annual total debt is $0.00

Total debt 1-year change

0%
DRMA {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
DRMA annual long term debt value is unknown

Short term debt

-
DRMA annual short term debt value is unknown

Equity & Capital

Shareholders equity

$1.56M
DRMA annual stockholders equity is $1.56 million

Book value

$1.56M
DRMA annual book value is $1.56 million

Retained earnings

-$65.68M
DRMA annual retained earnings is -$65.68 million

Working capital

$1.56M
DRMA annual working capital is $1.56 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.16M
DRMA annual cash flow from operations is -$11.16 million

Cash from operations 1-year change

-74.18%
DRMA annual cash flow from operations is down -74.18% year-on-year

Cash from investing

-
DRMA annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
DRMA annual cash flow from investing activities 1-year change is unknown

Cash from financing

$6.89M
DRMA annual cash flow from financing activities is $6.89 million

Cash from financing 1-year change

-9.46%
DRMA annual cash flow from financing activities is down -9.46% year-on-year

CAPEX

CAPEX

-
DRMA annual capital expenditures value is unknown

CAPEX 1-year change

-
DRMA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$11.16M
DRMA annual free cash flow is -$11.16 million

Free cash flow 1-year change

-74.18%
DRMA annual free cash flow is down -74.18% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
DRMA annual gross profit margin value is unknown

Operating margin

-
DRMA annual operating profit margin value is unknown

Net margin

-
DRMA annual net profit margin value is unknown

ROA & ROE

ROA

-347.70%
DRMA annual return on assets is -347.70%

ROE

-787.11%
DRMA annual return on equity is -787.11%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DRMA price to earnings ratio value is unknown

PE ratio Sector rank

-
DRMA price to earnings ratio is unknown

PB Ratio

PB ratio

2.54
DRMA price to book ratio is 2.54

PB ratio Sector rank

68.92%
DRMA price to book ratio is higher than 68.92% of companies in Healthcare sector

PS Ratio

PS ratio

-
DRMA price to sales ratio value is unknown

PS ratio Sector rank

-
DRMA price to sales ratio is unknown

Enterprise value

Enterprise value

$797.31K
DRMA enterprise value is $797.31 thousand

Enterprise value Sector rank

13.39%
DRMA enterprise value is higher than 13.39% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.06
DRMA EV/EBITDA is -0.06

EV/EBITDA Sector rank

63.01%
DRMA EV/EBITDA is higher than 63.01% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.79
DRMA annual current ratio is 1.79

Quick ratio

-
DRMA annual quick ratio value is unknown

Leverage

Debt to equity

0.00
DRMA annual debt to equity ratio is 0.00

Interest coverage ratio

-
DRMA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
DRMA piotroski f-score value is unknown

Altman Z-Score

-
DRMA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Aug 21, 24 Maxim Group
Buy
Mar 23, 23 Maxim Group
Buy
Sep 21, 21 Brookline Capital
Buy
Sep 14, 21 Maxim Group
Buy

Institutional Ownership

Similar stocks

RDHL logo
RedHill Biopharma (RDHL)
TCRT logo
Alaunos Therapeutics (TCRT)
CHEK logo
Check-Cap (CHEK)
OGEN logo
Oragenics (OGEN)
PRFX logo
PainReform (PRFX)
SONN logo
Sonnet BioTherapeutics Holdings (SONN)
NUWE logo
Nuwellis (NUWE)
TOVX logo
Theriva Biologics (TOVX)
XWEL logo
XWELL (XWEL)
  • What is the ticker symbol for Dermata Therapeutics?
  • Does Dermata Therapeutics pay dividends?
  • What sector is Dermata Therapeutics in?
  • What industry is Dermata Therapeutics in?
  • What country is Dermata Therapeutics based in?
  • When did Dermata Therapeutics go public?
  • Is Dermata Therapeutics in the S&P 500?
  • Is Dermata Therapeutics in the NASDAQ 100?
  • Is Dermata Therapeutics in the Dow Jones?
  • When was Dermata Therapeutics's last earnings report?
  • When does Dermata Therapeutics report earnings?
  • Should I buy Dermata Therapeutics stock now?

What is the ticker symbol for Dermata Therapeutics?

The ticker symbol for Dermata Therapeutics is NASDAQ:DRMA

Does Dermata Therapeutics pay dividends?

No, Dermata Therapeutics does not pay dividends

What sector is Dermata Therapeutics in?

Dermata Therapeutics is in the Healthcare sector

What industry is Dermata Therapeutics in?

Dermata Therapeutics is in the Biotechnology industry

What country is Dermata Therapeutics based in?

Dermata Therapeutics is headquartered in United States

When did Dermata Therapeutics go public?

Dermata Therapeutics's initial public offering (IPO) was on August 13, 2021

Is Dermata Therapeutics in the S&P 500?

No, Dermata Therapeutics is not included in the S&P 500 index

Is Dermata Therapeutics in the NASDAQ 100?

No, Dermata Therapeutics is not included in the NASDAQ 100 index

Is Dermata Therapeutics in the Dow Jones?

No, Dermata Therapeutics is not included in the Dow Jones index

When was Dermata Therapeutics's last earnings report?

Dermata Therapeutics's most recent earnings report was on Nov 15, 2021

When does Dermata Therapeutics report earnings?

The date for Dermata Therapeutics's next earnings report has not been announced yet

Should I buy Dermata Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page